Details of the Drug

General Information of Drug (ID: DM3PBMR)

Drug Name
INTERCEPT
Indication
Disease Entry ICD 11 Status REF
Blood transfusion QB98 Phase 3 [1]
Infectious disease 1A00-CA43.1 Phase 2 [2]
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
72385
TTD ID
D05JFA
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of Cerus.
2 ClinicalTrials.gov (NCT02310412) A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma. U.S. National Institutes of Health.